Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.

MLA

Calderón, José Meneses, et al. “Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 Patients with Risk Factors for Poor Prognosis: A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials, vol. 21, no. 1, June 2020, pp. 1–3. EBSCOhost, https://doi.org/10.1186/s13063-020-04448-2.

APA

Calderón, J. M., Zerón, H. M., & Padmanabhan, S. (2020). Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(1), 1–3. https://doi.org/10.1186/s13063-020-04448-2

Chicago

Calderón, José Meneses, Hugo Mendieta Zerón, and Srivatsan Padmanabhan. 2020. “Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 Patients with Risk Factors for Poor Prognosis: A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” Trials 21 (1): 1–3. doi:10.1186/s13063-020-04448-2.